BELANTAMAB MAFODOTIN vs BEMPEGALDESLEUKIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BELANTAMAB MAFODOTIN vs BEMPEGALDESLEUKIN: Safety Overview
| Metric | BELANTAMAB MAFODOTIN | BEMPEGALDESLEUKIN |
|---|---|---|
| Total FAERS Reports | 2,293 | 174 |
| Deaths Reported | 843 | 22 |
| Death Rate | 36.8% | 12.6% |
| Hospitalizations | 599 | 159 |
| Average Patient Age | 67.3 yrs | 64.9 yrs |
| % Female Patients | 39.2% | 23.6% |
| Manufacturer | GlaxoSmithKline LLC | N/A |
| Route | INTRAVENOUS | N/A |